|
HS Code |
158568 |
| Chemical Name | 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine |
| Molecular Formula | C12H7ClN2S |
| Molecular Weight | 246.72 g/mol |
| Cas Number | 957055-13-3 |
| Appearance | Off-white to pale yellow powder |
| Melting Point | Frequently reported between 203-208°C |
| Solubility | Slightly soluble in DMSO, DMF; insoluble in water |
| Boiling Point | Decomposition before boiling |
| Purity | Typically ≥98% (varies by supplier) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Iupac Name | 4-chloro-5-phenylthieno[2,3-d]pyrimidine |
| Smiles | C1=CC=C(C=C1)C2=CC3=NC=NC(Cl)=C3S2 |
As an accredited 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine, sealed with tamper-evident cap and labeled with safety information. |
| Shipping | Shipping for **4-Chloro-5-Phenylthieno[2,3-d]pyrimidine** must comply with standard chemical transport regulations. The compound should be securely sealed in appropriate, labeled containers and packed with cushioning material. Ship via certified carriers, with all documentation included. Handle and store away from incompatible substances, heat, and moisture to ensure safety and stability during transit. |
| Storage | 4-Chloro-5-Phenylthieno[2,3-d]pyrimidine should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from sources of heat and ignition. Protect from light and moisture. Store separately from incompatible substances, such as oxidizing agents. Ensure proper labeling and avoid inhalation, ingestion, or skin contact during handling. Follow all appropriate safety procedures and regulations. |
Applications of 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine in Industrial Manufacturing4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine has established itself as a valued intermediate for complex molecule synthesis in the pharmaceutical and fine chemical industries. Leveraging our manufacturing expertise, we support multiple industrial value chains with high-purity raw material optimized for large-scale downstream integration. Below, we detail core application scenarios, each matched to documented industry usage, reflecting strict compliance and process requirements. 1. Pharmaceutical Active Pharmaceutical Ingredient (API) SynthesisPharmaceutical companies utilize this intermediate within multi-step synthesis routes targeting targeted therapies, particularly kinase inhibitors and other specialty heterocyclic compounds. Integration of this thienopyrimidine core builds molecular complexity during late-stage synthesis under highly regulated conditions, requiring traceability and analytical support from initial delivery to final purification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient DevelopmentR&D and production teams in major agrochemical companies incorporate the thienopyrimidine fragment as an essential building block for synthesizing new-generation fungicides and herbicides. Its aromatic-chloro substitution pattern enhances biological selectivity, enabling development of patent-backed crop protection agents. Integration occurs during early-stage molecule assembly, where purity and homogeneity safeguard process scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Synthesis for Research and Specialty Chemical MarketsContract research organizations and advanced material solution providers exploit this compound to create high-value heterocyclic libraries required for structure-activity relationship studies and specialty electronic materials. When synthesizing novel thieno- and pyrimidine-derivatives, the purity and trace characterization of the input intermediate directly influences reproducible downstream results, particularly in gram-to-multikilogram lots. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Synthesis Contracts for Pharmaceutical CDMOsCustom development and manufacturing organizations (CDMOs) specify this thienopyrimidine intermediate in project-specific syntheses where control over impurity profiles and supply chain traceability determine batch release. These projects often target confidential client molecules for clinical development, requiring documentation that supports regulatory submissions and process validation data packages. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over years at the factory, we have handled nearly every class of heterocyclic compound. 4-Chloro-5-phenylthieno[2,3-d]pyrimidine takes a spot on the benchtop that gets more crowded every season, yet stands out in labs around the world for a good reason: its balanced structure and reactivity provide an edge others cannot. Manufacturing this compound on scale demands finesse. The raw starting thiophene rings challenge any operator’s skill, and the transition to a pyrimidine core calls on our chemists to control temperature, order of addition, and purification as tightly as the best watchmaker. From batch to batch, we deliver a product that those researchers depend on—consistent, clean, and fit for the most demanding work.
This compound’s backbone—where chlorination sits opposite a phenyl group on a fused thienopyrimidine ring—wasn’t stumbled upon by accident. Behind every shipment stands a line of operators, chemists, and quality control professionals, each one inspecting a crystallization or monitoring a spectral reading. Our facilities use multi-step syntheses, and we invest in targeted purification to strip out unwanted isomers or residual chlorinated materials. That extra attention strips away guesswork for those who need tight specifications in pharmaceutical discovery, advanced materials science, or specialty agrochemical synthesis.
From our earliest scale-ups we realized that purity and batch consistency are not empty promises—they’re achieved only with careful process engineering. We keep moisture and contaminant risk under tight control, only using sealed systems with inert atmospheres for sensitive conversion steps. Every ampule or drum shipped from our site represents that commitment: this is not a commodity to us; this is a handshake.
Research-grade 4-chloro-5-phenylthieno[2,3-d]pyrimidine can’t leave any doubt in chemical ID or purity. Laboratories send us feedback: “Spectra always match.” Our analysts confirm structure through NMR testing—none of those weed-seed contaminants or ambiguous extra peaks that can complicate scale-up for your project partner down the line. We maintain tight melting point ranges, keep residual solvents beneath industry minimums, and support every barrel or bottle with a history of analytical documentation, open for review.
This is not a material you scrape up from a reactor and call finished. At our site, we set up column purifications under pressure and controlled temperature, sometimes repeating steps that many would skip. That level of attention pays off for teams moving their drug candidates from discovery through pre-clinical synthesis—confidence in the batch means no worrying about re-testing, reformulating, or rejecting intermediates mid-process.
We started out producing this molecule for local medicinal chemistry teams, and along the way, saw first-hand how it bridges discovery and development. At its core, the thienopyrimidine skeleton opens up new pathways for synthetic chemists seeking kinase inhibitors, antiviral motifs, and materials with unique optoelectronic behavior. Once our material found its way to medicinal teams, they sent us data. They saw improved scaffold activity thanks to the well-positioned electron density from the chlorine and phenyl substituents.
On collaboration visits, process chemists pointed out that competitive products often come salted with side products from uncontrolled halogenation or incomplete condensation, which slows their ability to scale. Our manufacturing team made changes: we tuned the reaction profile, narrowed the temperature band, and improved our waste removal. In the end, researchers stopped flagging troublesome peaks in their chromatography. That’s when we knew we’d closed the loop.
We often compare our material with similar structures such as 4-chlorothieno[2,3-d]pyrimidine or 5-phenylthieno[2,3-d]pyrimidine, each missing one half of the “dial” this molecule sets for reactivity. Drop this specific compound in a catalytic screening campaign: chemists report reliable couplings with boronic acids, tell us the phenyl ring keeps substitution sites predictable, and mention how the chlorine actives selective SNAr reactions without drifting into unwanted side products.
Unlike close analogues, our version of 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine resists unwanted polymerization—an issue for partners working toward advanced materials—because our control in the aromatic substitution step eliminates active sites that would trigger runaway side reactions. Once our customers experienced fewer reaction failures and easier downstream purification, we saw demand shift in our favor, with repeat requests for kilogram-scale lots on tight timelines.
Teams in both pharmaceuticals and specialty chemical sectors rely on our product for tasks that punish impurity and inconsistency. In drug synthesis, this material serves as a hinge: it allows rapid parallel synthesis of libraries, giving project leads the tools to move quickly in lead optimization. In dye and materials labs, the fused heterocycle is prized for its extended conjugation and unique charge distribution, pushing boundaries in pigment or photoactive compound development.
Customers tell us their priorities differ depending on the field: pharma partners look for absolute batch purity and a COA that stands up to regulatory scrutiny, while material science teams prize structure confirmation and detailed analytical support. We run extra identity checks and work with outside reference labs to back up every assertion about what’s inside the drum before it leaves our dock.
Unlike high-volume commodity intermediates, our approach focuses on maintaining balance between output and quality. Production crews work hands-on with small and medium reactors, keeping a close eye on exotherms and gas evolution. On some batches, we pause after the chlorination step, sampling throughout, adjusting pressure and time based on the day’s readings and decades of hands-on know-how.
This approach limits error, and the downstream results bear it out. Regulatory audits and customer surprise inspections are a regular part of our schedule, not a disruption. We don’t wait for complaints. Instead, we review process logs, analytical runs, and partner feedback. This keeps the operation nimble—ready to scale up or modify production by request, without sacrificing the tight control applied to every kilo we deliver.
The field isn’t static. Over the past five years, demand for high unit purity has climbed, particularly as more medicinal chemistry teams look for ready-to-couple intermediates that avoid halogen “scrambling” or mystery ‘ghost peaks’ in analytic tests. Product teams pressing for faster project cycles push us to adapt our production windows and analytical techniques, speeding up release while keeping every result transparent and auditable.
Global events disrupted some chemical supply chains. We heard early about struggles with long lead times and sudden quality dips in generic suppliers. Because we handle every critical step ourselves under one roof, we offer what others cannot—predictability, plus accountability. Our process both protects the integrity of the final compound and makes requalification swift if project leaders request data going back years. For those running time-sensitive projects or scaling out multi-step campaigns, this reassurance matters more than a rock-bottom price tag.
Staff in both R&D and manufacturing know how one batch can speed up or slow down an entire campaign. If a synthetic route stalls because of trace impurities, whole project timelines can unravel. Since our team wears both development and production hats, we walk into every trial batch or scale-up thinking about what it will take to support the client a year down the line—what will stand up to scrutiny in both the data room and the regulatory audit.
4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine’s unique substitution pattern unlocks regioselectivity for creative synthesis. It provides every regimented step in combinatorial chemistry, and it offers flexible coupling options further down the pipeline. It’s a versatile tool meant for chemists who demand clarity and predictability in their workflows, backed by a manufacturer who makes no compromises in purity or process control.
Conversations with senior scientists often start with performance, but reach practical points quickly. “How does your batch behave with this catalyst system?” “Are you seeing any trace side reactions with palladium or copper?” We’ve seen the costs of leaving those questions unanswered. That’s why our technical support staff stay updated on the latest synthetic routes, and we keep an open line to project chemists needing direct answers from the people who actually made the batch. This is a big difference from anonymous traders or catalogue-only resellers.
Feedback from project teams shaped our choices in packing and shipment, so material arrives ready for immediate use, without additional drying or purification. For long-haul clients, we coordinate lot tracking and retain samples, ensuring any issue gets traced to source in hours, not weeks. This responsiveness matters most in campaigns stretching across multiple sites, bringing together teams that won’t tolerate supply chain questions they could have avoided.
Some competitors streamline production to maximize throughput, rolling out large lots at the cost of flexibility and specialty-grade control. Our approach runs the other way. We keep equipment spare for small campaign batches that need a higher level of oversight, adjusting timelines if an important customer project comes in. That way, if a pharma partner has new spectral standards or needs a 2D NMR run, we fold it in as part of the day’s work, not as an expensive add-on.
In real projects, these adjustments make the difference between a supply glitch and a seamless syntheses sequence. We’ve learned to anticipate changing research priorities—tailoring product grade, offering custom impurity profiling, or advising on downstream chemistry. This focus comes from direct experience, years spent standing at hot reactors and sifting residue under vacuum.
Every kilo of 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine we release is more than a bulk chemical: it’s the end point of thousands of manual entries, operator checks, and deliberate method choices. Customers rarely see that chain—but they experience the consistency first-hand. Our team’s willingness to adapt and refine process steps—sometimes at substantial cost—comes from seeing how critical each variable is to real-world outcomes.
Pharmaceutical groups come back project after project, citing not just purity, but the confidence in supply. Teams have pulled late nights with our support staff troubleshooting a batch or matching historical results for regulatory filings. We view these as part of our work, not a distraction. As the field keeps advancing toward more complex scaffolds and multi-step, sensitive syntheses, our intention remains: offer not just molecules, but the certainty that comes with working with those who produced them by hand, start to finish.
Chemical manufacturing doesn’t run itself. Experienced hands solve small problems before they grow, catch off-odors before contamination is visible, and understand from long habit which test result will satisfy a regulatory inspector. Our crew takes pride in knowing that each analysis, each packed bottle, represents more than standards: it stands for a process fine-tuned by people who care what happens when that chemical hits a bench on the other side of the world.
As new use cases emerge—in targeted synthesis, material applications, emerging API routes—we keep investing in process control and open documentation. Every customer inquiry is an invitation to improve, and each operational review a check on our methods. We make every adjustment knowing it delivers immediate value to those designing better medicines or materials today.
Demand for 4-Chloro-5-Phenylthieno[2,3-D]Pyrimidine is not standing still. As research pushes ever further, standards will only climb higher. We stand ready, backed by a workflow built for oversight, customization, and real relationships with the scientists putting our compounds to work. Our commitment runs deeper than just production numbers: it’s measured by every successful scale-up, every report free of unexplained byproducts, and every breakthrough our partners share back.